{
  "context": {
    "rules": [
      "Rule1: If the research team synthesizes the plant extract into a drug compound, then the company achieves commercialization of the new drug.",
      "Rule2: The plant extract passes safety review or the mineral compound passes safety review.",
      "Rule3: If the mineral compound passes safety review, then the research team does not receive private investment funding.",
      "Rule4: If the research team initiates human trials with the mineral compound, then the research team does not initiate human trials with the plant extract.",
      "Rule5: If the research team develops the final product formulation, then the company achieves commercialization of the new drug.",
      "Rule6: If the research team analyzes the bioavailability of the plant extract, then the research team develops the final product formulation.",
      "Rule7: If the research team analyzes the bioavailability of the mineral compound, then the research team develops the final product formulation.",
      "Rule8: If the company patents the plant extract formula, then the company patents the mineral compound formula.",
      "Rule9: The company patents the plant extract formula or the research team analyzes the bioavailability of the plant extract or the research team analyzes the bioavailability of the mineral compound.",
      "Rule10: If the research team synthesizes the mineral compound into a drug compound, then the company achieves commercialization of the new drug.",
      "Rule11: The research team identifies the active compound in the plant extract or the research team identifies the active compound in the mineral compound.",
      "Rule12: If the research team identifies the active compound in the mineral compound, then the research team synthesizes the mineral compound into a drug compound.",
      "Rule13: The research team tests the plant extract in vitro or the research team tests the mineral compound in vitro.",
      "Rule14: If the research team tests the mineral compound in vitro, then the research team synthesizes the mineral compound into a drug compound.",
      "Rule15: If the research team submits the plant extract to regulators, then, provided that testing the plant extract in vitro does not lead to synthesizing the plant extract into a drug compound, the manufacturing team designs a process for the plant extract.",
      "Rule16: The research team submits the plant extract to regulators or the research team submits the mineral compound to regulators.",
      "Rule17: If the research team submits the mineral compound to regulators, then, provided that testing the plant extract in vitro does not lead to synthesizing the plant extract into a drug compound, the manufacturing team designs a process for the plant extract.",
      "Rule18: If the research team publishes clinical trial findings, then the company achieves commercialization of the new drug.",
      "Rule19: The research team publishes clinical trial findings or the research team publishes laboratory results.",
      "Rule20: If the research team does not receive government grant funding and publishing laboratory results does not lead to the company achieving commercialization of the new drug, then the research team receives private investment funding.",
      "Rule21: If the plant extract passing safety review does not result in the research team not receiving private investment funding, then the research team initiates human trials with the plant extract.",
      "Rule22: If the plant extract passing safety review does not result in the research team not receiving private investment funding, then the research team initiates human trials with the mineral compound.",
      "Rule23: If identifying the active compound in the plant extract does not lead to synthesizing the plant extract into a drug compound, then the research team does not explore alternative sources for the plant extract.",
      "Rule24: If testing the plant extract in vitro does not lead to synthesizing the plant extract into a drug compound, then the manufacturing team does not design a process for the plant extract.",
      "Rule25: If the failure of identifying the active compound in the plant extract to lead to synthesizing the plant extract into a drug compound does not result in the research team exploring alternative sources for the plant extract, then the research team explores alternative sources for the mineral compound.",
      "Rule26: If the failure of identifying the active compound in the plant extract to lead to synthesizing the plant extract into a drug compound does not result in the research team exploring alternative sources for the plant extract, then the research team does not explore alternative sources for the mineral compound.",
      "Rule27: If the failure of testing the plant extract in vitro to lead to synthesizing the plant extract into a drug compound does not result in the research team investigating side effects of the plant extract, then the research team investigates side effects of the mineral compound."
    ],
    "facts": [
      "Fact1: The research team does not receive government grant funding.",
      "Fact2: The company does not patent the mineral compound formula.",
      "Fact3: The research team does not investigate side effects of the plant extract.",
      "Fact4: The research team does not investigate side effects of the mineral compound."
    ]
  },
  "question": "The company achieves commercialization of the new drug."
}